PIVI’s mission is to reduce the global disease burden from influenza and other respiratory viruses and improve national and global capacity to respond to pandemics and other epidemic threats.
The Partnership for International Vaccine Initiatives (PIVI) is a key program of The Task Force for Global Health. PIVI works in partnership with the Centers for Disease Control and Prevention, local Ministries of Health, corporate partners, and foundations to create sustainable vaccination programs in low- and middle-income countries.
Launched in 2013 as the Partnership for Influenza Vaccine Introduction, PIVI successfully built seasonal influenza programs to help protect communities from the annual impact of influenza while developing the vaccine delivery systems critical for endemic and pandemic responses. In 2020, these influenza programs proved valuable in the efficient distribution of the COVID-19 vaccine. Building on the successful PIVI model, the CDC partnered with PIVI to create the COVID-19 Vaccine Implementation Program (CoVIP). Since then, PIVI has expanded to reflect a broader mission of improving the capacities of low- to middle-income countries to prevent and respond to global health threats, protecting people of all ages.
PIVI works in concert with WHO and WHO Regional Offices to help countries prepare for endemics and pandemics by strengthening immunization programs. This important work is ultimately supported by local Ministries of Health.
In 2011, Walgreens approached the US Centers for Disease Control and Prevention with a question: Could donated excess influenza vaccine help a low-income country with its influenza program?
PIVI partners with low- and middle-income countries to create and strengthen vaccination programs to protect communities from the impacts of influenza and other respiratory viruses.
